Cell Therapy Technologies Market Size by Product (Media, Sera & Reagents, Cell Culture Vessels, Single-Use Equipment), Process (Cell Processing, Preservation), Cell type (T-Cells, Stem cells), End User (Biopharma, CROs, CMOs), Region - Global Forecast to 2028
The global size of cell therapy technologies market in terms of revenue was estimated to be worth USD 4.2 billion in 2023 and is poised to reach USD 7.8 billion by 2028, growing at a CAGR of 13.3% from 2023 to 2028. The research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
Increasing government investments in cell-based research, increased government and private funding and strong emphasis on the launch of novel products by key market players are driving the market growth.
Attractive Opportunities in the Cell Therapy Technologies Market
To know about the assumptions considered for the study, Request for Free Sample Report
Cell Therapy Technologies Market Dynamics
DRIVER: Rising incidence of chronic and infectious diseases
Cell therapy plays a crucial role in providing diagnostic and prognostic information for various diseases, including HIV/AIDS, cancer, and infectious diseases. Through innovative cellular-based approaches, it enables researchers and healthcare professionals to gain insights into disease mechanisms, disease progression, and treatment responses. The global population growth, climate change, and increased interaction between humans and animals have created an environment where the emergence of new virus outbreaks is more likely. Cell therapy research and applications are vital in addressing these challenges by providing advanced diagnostic tools, therapeutic interventions, and a deeper understanding of disease mechanisms.
RESTRAINT: High cost of cell-based research and low success rate
Cell biology research focuses on developing new therapies like stem cell and gene therapies. To obtain accurate results, high-quality instruments, reagents, and related products are essential. However, meeting regulatory guidelines and maintaining stringent quality standards in cell biology research incurs high costs. This poses a challenge for institutes and small-scale companies with limited budgets, as they may struggle to afford expensive research products.
OPPORTUNITY: Increased focus on personalized medicine
Precision medicine is an evolving approach to disease treatment and prevention that considers individual differences in genes, environment, and lifestyle. It involves tailoring drug selection to each patient based on their specific condition and medical history. While its application expands to various diseases, oncology has made notable progress in precision medicine. This personalized approach to diagnosis, treatment, and prevention utilizes comprehensive patient information, including genetics, environment, and lifestyle, to make more accurate decisions.
CHALLENGE: Survival of small players and new entrants
Small players and new entrants in the cell therapy technologies market face a significant challenge in terms of survival. Such as Thermo Fisher Scientific (US), Merck KGaA (Germany), Lonza (Switzerland), Sartorius AG (Germany), and Danaher (US) account for a major share of the market. This makes it challenging for smaller players and new entrants to compete effectively. Additionally, the market demands substantial investments in research and development (R&D) and the launch of innovative products, creating difficulties for smaller players to sustain their operations and compete with established players that have substantial R&D budgets.
Cell Therapy Technologies Market Ecosystem
The process segment dominated the cell therapy technologies industry in 2022.
Based on process, the global cell therapy technologies market is segmented into cell processing cell preservation, distribution and handling, process monitoring and quality control. Cell processing segment dominated process segment in 2022. Availability and launch of technologically advanced cell processing equipment is likely to contribute to the growth of the segment.
The biopharmaceutical & biotechnology companies segment accounted for the segment dominated cell therapy technologies industry in 2022.
Based on end users, the cell therapy technologies market is segmented into biopharmaceutical & biotechnology companies, CRO’s & CMOs, research institutes and cell banks. In 2022, biopharmaceutical and biotechnology companies held dominant share owing to various factors such as increased investment in development of cell based therapies. Rising research institutes and biopharma companies collaborations is further anticipated to drive the growth of the segment at faster pace.
North America held a dominant share in the regional market for the cell therapy technologies industry in 2022.
To know about the assumptions considered for the study, download the pdf brochure
Geographically, the cell therapy technologies markets are segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In 2022, North America accounted for the largest share of the cell therapy technologies market, followed by Europe & Asia Pacific. The region's dominant position can be attributed to several key factors such as presence of leading market players and increased government investments in cell-based research.
Key players in the cell therapy technologies market include Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Danaher Corporation (US), Becton, Dickinson, and Company (US), Lonza Group (Switzerland), Sartorius AG (Germany) and among others.
Scope of the Cell Therapy Technologies Industry
|
Report Metric |
Details |
|
Market Revenue in 2023 |
$4.2 billion |
|
Projected Revenue by 2028 |
$7.8 billion |
|
Revenue Rate |
Poised to Grow at a CAGR of 13.3% |
|
Market Driver |
Rising incidence of chronic and infectious diseases |
|
Market Opportunity |
Increased focus on personalized medicine |
This report categorizes the Cell therapy technologies market to forecast revenue and analyze trends in each of the following submarkets:
By Product
- Media, Sera, Reagents
- Cell Engineering products
- Cell Culture Vessels
-
Cell therapy Equipment
- Cell Processing Equipment
- Single Use Equipment
- Other Equipment
- System & Software
- Other Products
By Cell Type
- T-Cells
- Stem Cells
- Other Cells
By Cell Process
- Cell Processing
- Cell Preservation, Distribution, and Handling
- Process Monitoring and Quality Control
By End User
- Biopharmaceutical & Biotechnology companies
- CRO’s & CMO’s
- Research Institutes & Cell Banks
By Region
-
North America
- US
- Canada
-
Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe (RoE)
-
Asia Pacific (APAC)
- Japan
- China
- India
- Rest of Asia Pacific (RoAPAC)
- Latin America (LATAM)
- Middle East and Africa (MEA)
Recent Developments of Cell Therapy Technologies Industry
- In March 2023, Thermo fisher scientific Inc. entered into collaboration with Arsenal biosciences Inc. The collaboration allows development of manufacturing process for new cancer treatments. This research and process development-focused collaboration has enabled ArsenalBio to develop a robust manufacturing process for their next-generation, programmable autologous T cells for the treatment of cancer.
- In March 2023, Danaher entered into partnership with the University of pennsylvania's center for cellular immunotherapies to solve manufacturing difficulties that are affecting the adoption of cell therapies.
- In March 2023, Lonza and Vertex have entered a strategic collaboration to facilitate the manufacturing of Vertex's portfolio of investigational stem cell-derived islet cell therapies. As part of the collaboration, Vertex and Lonza will establish a dedicated manufacturing facility specifically for T1D cell therapies.
Frequently Asked Questions (FAQ):
What is the projected market revenue value of the global cell therapy technologies market?
The global cell therapy technologies market boasts a total revenue value of $7.8 billion by 2028.
What is the estimated growth rate (CAGR) of the global cell therapy technologies market?
The global cell therapy technologies market has an estimated compound annual growth rate (CAGR) of 13.3% and a revenue size in the region of $4.2 billion in 2023.
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
This study involved four major activities in estimating the current size of the cell therapy technologies market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. The top-down and other approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.
Secondary Research
Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the cell therapy technologies market. Some of the key secondary sources referred to for this study include publications from government sources World Health Organization (WHO), the US Food and Drug Administration (FDA), the National Institutes of Health (NIH), the National Center for Biotechnology Information (NCBI). World Health Organization (WHO), CDC, International Society for Stem Cell Research, International Society for Cellular Therapy (ISCT), American Society of Gene & cell therapy (ASGCT), International cell Research Organization (ICRO), European Society of Gene and cell therapy (ESGCT), American Society for cell Biology, California Institute for Regenerative Medicine (CIRM), National Institute of Cancer (NIC), National Cancer Institute (NCI), Association of American Cancer Institutes (AACI).These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives. Secondary sources also include corporate and regulatory filings (such as annual reports, SEC filings, investor presentations, and financial statements); business magazines and research journals; press releases; and trade, business, and professional associations. Secondary data was collected and analyzed to arrive at the overall size of the global cell therapy technologies market, which was validated through primary research.
Primary Research
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess future prospects of the market. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The global size of the cell therapy technologies market was estimated through multiple approaches. A detailed market estimation approach was followed to estimate and validate the value of the market and other dependent submarkets. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The major players in the industry and market have been identified through extensive primary and secondary research.
- The revenues generated from the cell therapy technologies business of players operating in the market have been determined through secondary research and primary analysis.
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
Top-down Approach-
To know about the assumptions considered for the study, Request for Free Sample Report
Data Triangulation
After estimating the overall market size through the market size estimation process, the total market was further separated into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Cell therapy refers to the introduction of new and healthy cells into the patient’s body to replace diseased or missing ones. New technologies and innovative products have enabled many different types of cells to treat diseases and conditions. Some of these cells are hematopoietic (blood-forming) stem cells (HSCs), skeletal muscle stem cells, mesenchymal stem cells, lymphocytes, dendritic cells, and pancreatic islet cells.
Cell therapy instruments are used in different cell processing stages, such as cell preservation & handling and process monitoring & quality control. These instruments are also used for clinical stem cell therapy and immunotherapy research & manufacturing.
Key Stakeholders
- Manufacturers, importers & exporters, traders, distributors, and suppliers of cell therapy technologies
- Cell therapy products manufacturers, suppliers, and processors
- Distributors and suppliers of cell therapy products
- Biotechnology and biopharmaceutical companies
- Contract manufacturing organizations (CMOs)
- Suppliers and distributors of pharmaceutical products
- Research and development (R&D) companies
- Pharmaceutical/medical associations
- Trade associations and industry bodies
- R Research institutes and government organizations
- Venture capitalists and investors
- Business research and consulting service providers
- Market research and consulting firms regulatory bodies and government agencies
Report Objectives
- To define, describe, segment, and forecast the cell therapy technologies market by product, process, cell type, end user, and region
- To provide detailed information about the factors influencing the market growth (drivers, restraints, opportunities, Challenges)
- To analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall cell therapy technologies market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the cell therapy technologies market in four main regions, namely, North America, Europe, Asia Pacific, Latin America and the Middle East and Africa.
- To profile the key players in the global cell therapy technologies market and comprehensively analyze their core competencies2 and market shares
- To track and analyze competitive developments, such as product launches, funding and grants, partnerships, agreements, collaborations, expansions, strategic alliances, and acquisitions in the Cell therapy Technologies market.
- To benchmark players within the market using the proprietary “Competitive Leadership Mapping” framework, which analyzes market players on various parameters within the broad categories of business and product excellence strategy.
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:
Geographic Analysis
- Further breakdown of the Rest of Europe's Cell therapy technologies market, by country
- Further breakdown of the Rest of Asia Pacific Cell therapy technologies market, by country
- Further breakdown of the Rest of Latin America and Middle East & Africa Cell therapy technologies market, by country
Company Information
- Detailed analysis and profiling of additional market top players (Up to 5)
Company Information
- An additional five company profiles
Growth opportunities and latent adjacency in Cell Therapy Technologies Market